DrAIStudio

Frontiers in Hematology call for papers

Current call-for-papers opportunities for Frontiers in Hematology. Ranking signals: Indexed (Active). Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Frontiers in Hematology

Viral Infections in Hematologic Malignancies: Clinical Impact, Prevention, and Management in the Era of Novel Therapies

Deadline 2027-05-10FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Infectious complications remain among the leading causes of morbidity and mortality in patients diagnosed with hematologic malignancies. While bacterial and ...

Viral Infections in Hematologic Malignancies: Clinical Impact, Prevention, and Management in the Era of Novel Therapies

Deadline 2027-05-10FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Infectious complications remain among the leading causes of morbidity and mortality in patients diagnosed with hematologic malignancies. While bacterial and ...

Integrative and Patient-Centered Care in Hematology

Deadline 2027-05-16FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Advances in the diagnosis and treatment of hematologic diseases — from chronic lymphocytic leukemia and lymphomas to myeloproliferative neoplasms and other b...

Integrative and Patient-Centered Care in Hematology

Deadline 2027-05-16FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Advances in the diagnosis and treatment of hematologic diseases — from chronic lymphocytic leukemia and lymphomas to myeloproliferative neoplasms and other b...

Advancing Genetic Therapies for Sickle Cell Disease: Gene Addition, Genome Editing, in vivo Delivery and Long-term Safety

Deadline 2027-05-18FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Sickle cell disease is entering a new era in which genetic therapies offer the potential for durable clinical benefits. Gene addition and genome editing have...

Advancing Genetic Therapies for Sickle Cell Disease: Gene Addition, Genome Editing, in vivo Delivery and Long-term Safety

Deadline 2027-05-18FrontiersIndexed (Active)

Journal: Frontiers in Hematology

Sickle cell disease is entering a new era in which genetic therapies offer the potential for durable clinical benefits. Gene addition and genome editing have...

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.